Investor Backing & Capital Strength:
Recent securitizations and facility upsizes—culminating in a July 2026 $525 million raise that lifted committed capacity to nearly $700 million—signal strong access to capital and liquidity for expansion. The July ABS was reported as oversubscribed, reinforcing capital‑markets support.
Strong Revenue Growth:
Appearance on the 2026 Inc. 5000 list, which ranks companies by multi‑year revenue growth, points to a rising top line. This recognition sits alongside stepped‑up origination capacity and cumulative funding that has surpassed $5 billion since inception.
Product Line Growth:
The company now offers both revenue‑based financing and loans with ticket sizes from roughly $5,000 to $500,000, expanding beyond its original focus. This broader product set can widen addressable demand and support scaling.
